[1]
Wu, H-Z.; Xiao, J-Q.; Xiao, S-S.; Cheng, Y. KRAS: A promising therapeutic target for cancer treatment. Curr. Top. Med. Chem., 2019, 19(23), 2081-2097.
[2]
Chen, F.; Alphonse, M.P.; Liu, Y. Liu, Q. Targeting mutant KRAS for anticancer therapy. Curr. Top. Med. Chem., 2019, 19(23), 2098-2113.
[3]
Ye, N.; Xu, Q.; Li, W.; Wang, P.; Zhou, J. Recent advances in developing k-ras plasma membrane localization inhibitors. Curr. Top. Med. Chem., 2019, 19(23), 2114-2127.
[4]
He, H.; Xu, C.; Cheng, Z.; Qian, X.; Zheng, L. Drug combinatorial therapies for the treatment of KRAS mutated lung cancers. Curr. Top. Med. Chem., 2019, 19(23), 2128-2142.
[5]
Shao, Y-T.; Ma, L.; Zhang, T-H.; Xu, T-R.; Ye, Y-C.; Liu, Y. The application of the RNA interference technologies for KRAS: current status, future perspective and associated challenges. Curr. Top. Med. Chem., 2019, 19(23), 2143-2157.
Current Topics in Medicinal Chemistry
Title:Drug Discovery by Targeting Mutant KRAS
Volume: 19 Issue: 23
Author(s): Na Ye
Affiliation:
Export Options
About this article
Cite this article as:
Ye Na , Drug Discovery by Targeting Mutant KRAS, Current Topics in Medicinal Chemistry 2019; 19 (23) . https://dx.doi.org/10.2174/156802661923191113144238
DOI https://dx.doi.org/10.2174/156802661923191113144238 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
40
3
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
From Amino Acids to Proteins as Targets for Metal-based Drugs
Current Drug Metabolism Characterization and Immunological Evaluation of Low-Molecular- Weight Alginate Derivatives
Current Topics in Medicinal Chemistry Synergistic Antitumor Effect of 5-Fluorouracil Combined with Constituents from <i>Pleurospermum lindleyanum</i> in Hepatocellular Carcinoma SMMC-7721 Cells
Anti-Cancer Agents in Medicinal Chemistry Berberine Interfered with Breast Cancer Cells Metabolism, Balancing Energy Homeostasis
Anti-Cancer Agents in Medicinal Chemistry Cancer-associated Autoantibodies as Biomarkers for Early Detection and Prognosis is Cancer: An Update
Current Cancer Therapy Reviews MicroRNAs in Colorectal Neoplasia: From Pathobiology to Clinical Applications
Current Pharmaceutical Biotechnology DNA Methylation in Colon Cancer: Challenges and Opportunities
Epigenetic Diagnosis & Therapy (Discontinued) Phytochemicals as Adjunctive with Conventional Anticancer Therapies
Current Pharmaceutical Design Mechanisms of Allostery and Membrane Attachment in Ras GTPases: Implications for Anti-Cancer Drug Discovery
Current Medicinal Chemistry Ruthenium Complexes: An Emerging Ground to the Development of Metallopharmaceuticals for Cancer Therapy
Mini-Reviews in Medicinal Chemistry Cyclooxygenase as a Target for Colorectal Cancer Chemoprevention
Current Drug Targets Malignant Mesothelioma: Biology, Diagnosis and Therapeutic Approaches
Current Molecular Pharmacology EGFR Expression Correlates with Maximum Standardized Uptake Value of 18F- fluorodeoxyglucose-PET in Squamous Cell Lung Carcinoma
Current Radiopharmaceuticals Regulation of Tumor Angiogenesis by the Immune System
Current Angiogenesis (Discontinued) Proliferation of Breast Cancer Cells: Regulation, Mediators, Targets for Therapy
Anti-Cancer Agents in Medicinal Chemistry Human Endometrial and Ovarian Cancer Cells: Histone Deacetylase Inhibitors Exhibit Antiproliferative Activity, Potently Induce Cell Cycle Arrest, and Stimulate Apoptosis
Current Medicinal Chemistry Role of Stem Cells in Colorectal Cancer Progression and Prognostic and Predictive Characteristics of Stem Cell Markers in Colorectal Cancer
Current Stem Cell Research & Therapy Review of QSAR for DNA Polymerase Inhibitors and New Models for Heterogeneous Series of Compounds
Current Computer-Aided Drug Design MicroRNAs for Diagnosis and Treatment of Colorectal Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets Anti-Vascular Endothelial Growth Factor Treatment in Retinal Vein Occlusions
Current Drug Therapy